Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Nash symbols : GILD save search
GENFIT: FNIH NIMBLE Study Demonstrates NIS4® Technology’s Unique Performance in Identifying Patients with “at-risk” NASH
Published: 2021-11-18 (Crawled : 22:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.36%
H: 0.3%
C: -0.65%
ICPT | $19.0 -0.05% 4M
|
Health Technology
|
| O: -1.54%
H: 2.15%
C: 0.06%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.59%
H: 1.04%
C: 0.74%
GNFT | $3.59 4.03% 2.1K
|
Health Technology
|
| O: 5.07%
H: 1.14%
C: -0.27%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.61%
H: 0.45%
C: 0.39%
nis4 unique risk technology nash
FDA Grants Marketing Authorization to Siemens Healthineers ELF Test for NASH Prognostic Assessment
Published: 2021-08-24 (Crawled : 18:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.11%
H: 0.08%
C: -0.52%
fda test nash authorized granted grant
Gilead and Novo Nordisk Expand NASH Clinical Collaboration
Published: 2021-03-18 (Crawled : 12:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.43%
H: 0.99%
C: 0.23%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -1.24%
H: 2.14%
C: 0.72%
collaboration nash expansion
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.